We are live on ! Find out more
MBOT icon

Microbot Medical
MBOT

29 hedge funds and large institutions have $381K invested in Microbot Medical in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

3.2% more ownership

Funds ownership: 4.19% → 7.39% (+3.2%)

0% more funds holding

Funds holding: 29 → 29 (0)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

58% less capital invested

Capital invested by funds: $910K → $381K (-$529K)

Holders
29
Holders Change
–
Holders Change %
0%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
2
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$260K
2
SM
Sabby Management
Florida
+$124K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$83.8K
4
Citadel Advisors
Citadel Advisors
Florida
+$51.6K
5
UBS Group
UBS Group
Switzerland
+$24K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$280K
2
Barclays
Barclays
United Kingdom
-$38.3K
3
Deutsche Bank
Deutsche Bank
Germany
-$3K
4
SPIA
Steward Partners Investment Advisory
New York
-$1K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$8
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$150K +$124K +32,725 +60%
Renaissance Technologies
2
Renaissance Technologies
New York
$118K +$260K +68,849 New
Geode Capital Management
3
Geode Capital Management
Massachusetts
$38K +$83.8K +22,151 New
Dimensional Fund Advisors
4
Dimensional Fund Advisors
Texas
$23K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$23K +$51.6K +13,653 New
UBS Group
6
UBS Group
Switzerland
$11K +$24K +6,341 +105,683%
BlackRock
7
BlackRock
New York
$8K – – –
Citigroup
8
Citigroup
New York
$6K +$13.2K +3,500 +87,500%
Barclays
9
Barclays
United Kingdom
$1K -$38.3K -10,122 -95%
AG
10
Advisor Group
Arizona
$1K – – –
Morgan Stanley
11
Morgan Stanley
New York
$1K +$2.01K +531 +738%
Bank of America
12
Bank of America
North Carolina
$1K +$2.26K +597 +1,218%
FDCDDQ
13
Federation des caisses Desjardins du Quebec
Quebec, Canada
$7 – – –
RE
14
RBC Europe
United Kingdom
$2 – – –
Vanguard Group
15
Vanguard Group
Pennsylvania
– -$280K -37,903 Closed
Deutsche Bank
16
Deutsche Bank
Germany
– -$3K -348 Closed
SPIA
17
Steward Partners Investment Advisory
New York
– -$1K -67 Closed
Royal Bank of Canada
18
Royal Bank of Canada
Ontario, Canada
– -$8 -2 -67%
CIA
19
Cascade Investment Advisors
Oregon
– -$7 -1 Closed
Bank of Montreal
20
Bank of Montreal
Ontario, Canada
– +$4 +1 +50%
Fidelity Investments
21
Fidelity Investments
Massachusetts
– +$4 +1 New
WCM
22
WealthBridge Capital Management
Ohio
– +$4 +1 New
Wells Fargo
23
Wells Fargo
California
– +$4 +1 +0.5%
BAM
24
Bruderman Asset Management
New York
– +$8 +2 New
Northwestern Mutual Wealth Management
25
Northwestern Mutual Wealth Management
Wisconsin
– +$110 +29 New
1
2

MBOT Hedge Fund Activity: Q4 2018 in Review

29 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q4 2018, worth a combined $381K — down 58% from $910K a quarter earlier.

Fund positioning in MBOT was balanced in Q4 2018: 8 funds opened new positions, 8 closed out, 7 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $260K. The largest seller was Vanguard Group, exiting entirely with an estimated $280K sold.

  • 29 institutional investors held Microbot Medical (MBOT) as of Q4 2018, unchanged from Q3 2018.
  • Funds reported $381K of Microbot Medical stock for Q4 2018, down 58% quarter-over-quarter.
  • 8 funds opened new Microbot Medical positions in Q4 2018 and 8 closed out, a net change of 0 holders.
  • The largest Microbot Medical buyer in Q4 2018 was Renaissance Technologies, an estimated $260K added.
  • The largest Microbot Medical seller in Q4 2018 was Vanguard Group, an estimated $280K sold.

Based on aggregated 13F filings for Q4 2018.